Mediastinal lymph node enlargement predicts progressive pulmonary fibrosis

Area of Science:

• Pulmonology
• Radiology
• Pathology

Background:

• Interstitial lung diseases (ILDs) encompass a group of disorders characterized by progressive pulmonary fibrosis (PPF).
• Identifying reliable predictors of PPF and prognosis in ILDs is crucial for patient management.
• Mediastinal lymph node enlargement (MLNE) is a radiographic finding observed in some ILD patients.

Purpose of the Study:

• To investigate the association between mediastinal lymph node enlargement (MLNE) and the prediction of progressive pulmonary fibrosis (PPF).
• To evaluate MLNE as a prognostic factor in patients with various interstitial lung diseases (ILDs).

Main Methods:

• Retrospective review of clinical, radiographic, and laboratory data from 800 hospitalized ILD patients.
• Analysis of the prevalence of MLNE and its correlation with fibrosis scores and mortality.
• Multivariable analysis to identify risk factors for PPF and overall prognosis.

Main Results:

• MLNE was identified in 39.1% of ILD patients, associated with higher fibrosis scores and increased mortality risk.
• MLNE was a significant independent predictor of PPF, alongside age and total fibrosis extent.
• Age, lactate dehydrogenase, MLNE, total fibrosis score, and pulmonary arterial systolic pressure were identified as risk factors in multivariable analysis.

Conclusions:

• Mediastinal lymph node enlargement (MLNE) is associated with increased fibrosis and poorer prognosis in ILD patients.
• MLNE serves as a valuable predictor for the development of progressive pulmonary fibrosis (PPF).
• While the total pulmonary fibrosis score is a universal prognostic factor across ILD subgroups, MLNE offers specific predictive value.